4,015 apr 2026Research associateEx dipendenteDurham, NCConsigliaGradimento del CEOPronostico commercialeVantaggiInnovative, robust leadership, community valuesSvantaggiPost merger confusion led to more problems in daily workflowsMostra di più
5,01 feb 2026Senior directorDipendente attuale, più di 3 anniStamford, CTConsigliaGradimento del CEOPronostico commercialeVantaggiThe culture- hype is real. Hands down, best culture I’ve ever worked in. Lets hope EMDS/ Merck KGaA doesn’t ruin it.SvantaggiThe acquisition has been tough. Feels like we’ve joined a sinking ship. A lot of meetings, but real work doesn’t get done.Mostra di piùUtileCondividi
5,023 lug 2025DirectorDipendente attualeDurham, NCConsigliaGradimento del CEOPronostico commercialeVantaggiRemote, independent work; dedicated coworkersSvantaggiResources as expected for midsize (capabilities/amenities of large pharma are not available)Mostra di piùUtileCondividi